Sugi Predict

Sugi Predict / Compounds / SCHEMBL5676733

SCHEMBL5676733

SCHEMBL5676733

CCC(C(=O)OC(C)=O)C(O)(CC(=O)O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSPD1 P10809 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ HSPE1 P61604 1/20 0.46
▸ CPT2 P23786 1/20 0.42
▸ ACLY P53396 1/20 0.42
▸ MEN1 O00255 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.32
▸ HMGCR P04035 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ TBXA2R P21731 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ CYP2D6 P10635 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ HIF1A Q16665 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5673360 0.87 HSPD1 (0.51) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL608369 0.84 HSPD1 (0.60) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL4481087 0.83 HSPD1 (0.67) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL4942635 0.83 HSPD1 (0.49) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL2008302 0.82 HSPD1 (0.69) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL15321744 0.82 HSPD1 (0.69) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL17812674 0.82 HSPD1 (0.69) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL3800160 0.81 HSPD1 (0.39) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL4266190 0.81 HSPD1 (0.49) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL2786298 0.79 CPT2 (0.44) HSPD1BLMHSPE1CPT2ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111298667-B Polymer-based blended film, and preparation method and application thereof 中国科学院大连化学物理研究所 2021-12-07 — — CN claimed
CN-107955350-B Full-biodegradable drug-resistant mulching film composition and preparation method thereof 山东天野生物降解新材料科技有限公司 2020-07-21 — — CN claimed
CN-107936507-B Mulching film for inhibiting weed growth and preparation method thereof 山东天野生物降解新材料科技有限公司 2020-01-14 — — CN claimed
EP-2623096-B1 Pharmaceutical composition with slow release of trimetazidine SERVIER LAB (FR) 2019-04-03 — — EP claimed
US-10117838-B2 Pharmaceutical composition for the prolonged release of trimetazidine LES LABORATOIRES SERVIER (FR) 2018-11-06 — — US claimed
US-20130202710-A1 PHARMACEUTICAL COMPOSITION FOR THE PROLONGED RELEASE OF TRIMETAZIDINE LES LABORATOIRES SERVIER (FR) 2013-08-08 — — US claimed
US-6983801-B2 Well treatment fluid compositions and methods for their use BJ SERVICES COMPANY (US) 2006-01-10 — — US claimed
US-20050016733-A1 Well treatment fluid compositions and methods for their use COMBINED SYSTEMS, INC. 2005-01-27 — — US claimed
US-6793018-B2 Solvent (such as water), a polymer soluble or hydratable in the solvent, a crosslinking agent such as a borate, an inorganic breaking agent, and an ester such as acetyl triethyl citrate; initial high viscosity, then low viscosity BJ SERVICES COMPANY 2004-09-21 — — US claimed
US-20020125012-A1 Well treatment fluid compositions and methods for their use BJ SERVICES COMPANY 2002-09-12 — — US claimed
WO-2002055843-A1 WELL TREATMENT FLUID COMPOSITIONS AND METHODS FOR THEIR USE BJ SERVICES COMPANY (US) 2002-07-18 — — WO claimed
EP-4419510-B1 NOVEL TRIMETAZIDINE SALTS SERVIER LAB (FR) 2025-10-08 — — EP disclosed
US-20250250245-A1 TRIMETAZIDINE SALTS LES LABORATOIRES SERVIER (FR) 2025-08-07 — — US disclosed
CN-118076591-A Novel trimetazidine salts 法国施维雅药厂 2024-05-24 — — CN disclosed
CN-115160752-B Polylactic acid composite material for mulching film and application thereof 山西生物质新材料产业研究院有限公司 2023-08-01 — — CN disclosed
US-10117838-B2 Pharmaceutical composition for the prolonged release of trimetazidine LES LABORATOIRES SERVIER (FR) 2018-11-06 — — US disclosed
CN-104302272-B Cosmetic composition comprising at least one alkoxysilane 欧莱雅公司 2018-07-20 — — CN disclosed
EP-2612650-B1 MANICURE COMPOSITION MITSUBISHI PENCIL CO (JP) 2017-07-05 — — EP disclosed
CN-104302272-A Cosmetic composition comprising at least one alkoxysilane OREAL 2015-01-21 — — CN disclosed
US-20130202710-A1 PHARMACEUTICAL COMPOSITION FOR THE PROLONGED RELEASE OF TRIMETAZIDINE LES LABORATOIRES SERVIER (FR) 2013-08-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250245-A1 TRIMETAZIDINE SALTS TRIM4, NNMT, NOX5 HSPD1 1121/4885BLM 2075/4885HSPE1 1468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.